Vitamin B12 Deficiency: Role and Treatment
Vitamin B12 deficiency requires prompt treatment with either intramuscular hydroxocobalamin or high-dose oral supplementation, with treatment protocols determined by the presence of neurological symptoms and the underlying cause of deficiency. 1, 2
Diagnosis and Clinical Presentation
- Vitamin B12 deficiency presents with hematological abnormalities (megaloblastic anemia) and/or neurological symptoms including paraesthesia, numbness, muscle weakness, abnormal reflexes, gait ataxia, and myelopathies 3
- Diagnosis should include serum B12 levels and functional biomarkers such as homocysteine and methylmalonic acid, as metabolic B12 deficiency can occur even with normal serum B12 levels 3, 2
- Metabolic B12 deficiency is defined as serum B12 below 258 pmol/L with elevated plasma total homocysteine or methylmalonic acid 3
- Elderly individuals have higher risk of B12 deficiency, with metabolic B12 deficiency present in 18.1% of patients over 80 years 3
Treatment Protocols
Based on Clinical Presentation
For patients with neurological involvement:
For patients without neurological involvement:
Based on Cause of Deficiency
Malabsorption (pernicious anemia, ileal resection, bariatric surgery):
Dietary deficiency:
Special Considerations
- Methylcobalamin or hydroxocobalamin may be preferable to cyanocobalamin in patients with renal dysfunction 3
- Never administer folic acid before treating vitamin B12 deficiency, as it may mask underlying B12 deficiency and precipitate subacute combined degeneration of the spinal cord 1, 2
- B12 deficiency is associated with increased risk of stroke due to hyperhomocysteinemia; supplementation with B vitamins can reduce stroke risk by 43% 3
- Target homocysteine level should be <10 μmol/L for optimal results 3, 1
Monitoring
- Monitor neurological symptoms regularly during treatment, as improvement indicates effective therapy 1
- In patients with deficiency, monitoring should occur every 3 months until stabilization, then once a year 1
- Serum B12 and total homocysteine should be measured to assess vitamin B12 status 3, 1
High-Risk Populations
- Elderly individuals (>80 years): 18.1% have metabolic B12 deficiency 3
- Patients after bariatric surgery require close monitoring and supplementation 1, 5
- Patients with ileal Crohn's disease involving more than 30-60 cm of ileum 1
- Vegans and strict vegetarians 1, 5
- Patients taking metformin for more than four months or proton pump inhibitors/H2 blockers for more than 12 months 5
B12 deficiency is a significant but often overlooked condition with potentially irreversible neurological consequences if left untreated. Early diagnosis and appropriate treatment are essential to prevent permanent neurological damage 3, 2.